期刊文献+

托拉塞米辅助治疗慢性心功能不全的疗效观察 被引量:1

Holds Lasser rice assistance treatment chronic heart function not entire curative effect observation
原文传递
导出
摘要 目的:探讨托拉塞米辅助治疗慢性心功能不全的临床疗效。方法:选择我院收治的慢性心功能不全患者90例,随机分为2组,在对两组常规用药的基础上,对观察组45例采用托拉塞米辅助治疗,对照组45例采取呋塞米辅助治疗。结果:给药前后患者心流动力学、心电图、心率、呼吸两组均未出现明显差异,观察组首剂静脉给药较对照组首剂给药作用时间延长明显(P〈0.01),观察组在首剂给药后,血液电解质波动范围在尿量达500ml时明显缩小(P〈0.05,或P〈0.01),观察组在oh-12h的尿量明显高于对照组。结论:托拉塞米辅助治疗慢性心功能不全疗效肯定,在心功能、机体内环境的稳定性和利尿作用的改善明显优于呋塞米。 Objective:The discussion holds the Lasser rice assistance treatment chronic heart function not entire clinical curative effect. Methods:Chooses my courtyard admitting the chronic heart function not entire patient 90 examples,divides into 2 groups stochastically, in to two group of conventional medication foundation in, uses to the observation group 45 examples holds the I.asser rice assistance treatment,the control group 45 examples to adopt fu fills the rice assistance treatment. Results: For the medicine around the patient heart flow mechanics, the electrocardiogram, the heart rate, breathe two groups not to have the obvious difference, the ob- servation group first medicinal preparation vein compare the control group first medicinal preparation for the medicine to lengthen obviously for the medicine response time(P〈0.01) ,the observation group after the first medicinal preparation for the medicine,the blood electrolyte undulation scope reaches 500ml when the amount of urine the obvious reduction(P〈0.05, or P〈0.01 ), the observation group is higher than the control group obviously in the Oh-12h amount of urine. Conclusion: Holds the Lasser rice assistance treatment chronic heart function not entire curative effect to affirm that,in the heart function,organism inner rim boundary stability and the diuresis function improvement surpasses obviously fu fills the rice.
作者 余庆锁
出处 《按摩与康复医学》 2010年第34期35-35,共1页 Chinese Manipulation and Rehabilitation Medicine
关键词 托拉塞米 呋塞米 慢性心功能不全 利尿剂 Holds Lasser Mi Fu to fill the rice Chronic heart function not entire Diuretic
  • 相关文献

参考文献2

二级参考文献15

  • 1王晓华,姚恒臣,吴兴利,周敏,于珂,孔祥泉,蔡孔长.长期β-受体阻滞剂治疗对充血性心力衰竭患者QT离散度和预后的影响[J].中国全科医学,2005,8(6):454-455. 被引量:7
  • 2Hunt SA,Abraham WT,Chin MH,et al.ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure):developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation:endorsed by the Heart Rhythm Society[J].Circulation,2005,112:e154-235.
  • 3Swedberg K,Cleland J,Dargie H,et al.Guidelines for the diagnosis and treatment of chronic heart failure:executive summary (update 2005):The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology[J].Eur Heart J,2005,26:1115-1140.
  • 4Hjalmarson A,Goldstein S,Fagerberg B,et al.Effects of controlled-release metoprolol on total mortality,hospitalizations,and well-being in patients with heart failure:the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF).MERIT-HF Study Group[J].JAMA,2000,283:1295-1302.
  • 5CIBIS Ⅱ Investigators and Committees.The Cardiac Insufficiency Bisoprolol Study Ⅱ (CIBIS-Ⅱ):a randomised trial[J].Lancet,1999,353:9-13.
  • 6Packer M,Coats AJ,Fowler MB,et al.Effect of carvedilol on survival in severe chronic heart failure[J].N Engl J Med,2001,344:1651-1658.
  • 7Poole-Wilson PA,Swedberg K,Cleland JG,et al.Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET):randomised controlled trial[J].Lancet,2003,362:7-13.
  • 8Willenheimer R,van Veldhuisen DJ,Silke B,et al.Effect on survival and hospitalization of initiating treatment for chronic heart failure with bisoprolol followed by enalapril,as compared with the opposite sequence:results of the randomized Cardiac Insufficiency Bisoprolol Study (CIBIS) Ⅲ[J].Circulation,2005,112:2426-2435.
  • 9Pitt B,Williams G,Remme W,et al.The EPHESUS trial:eplerenone in patients with heart failure due to systolic dysfunction complicating acute myocardial infarction.Eplerenone Post-AMI Heart Failure Efficacy and Survival Study[J].Cardiovasc Drugs Ther,2001,15:79-87.
  • 10Moss AJ,Zareba W,Hall WJ,et al.Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction[J].N Engl J Med,2002,346:877-883.

共引文献44

同被引文献6

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部